A. Kraszewski

1.0k total citations
9 papers, 777 citations indexed

About

A. Kraszewski is a scholar working on Genetics, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A. Kraszewski has authored 9 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Oncology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A. Kraszewski's work include Estrogen and related hormone effects (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). A. Kraszewski is often cited by papers focused on Estrogen and related hormone effects (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). A. Kraszewski collaborates with scholars based in United Kingdom, Australia and India. A. Kraszewski's co-authors include Robert Lindsay, D.M. Hart, Allan MacLean, Jane Garwood, Adh Clark, D. M. Hart, Ann S. Clark, M.M. Ferguson, D.W. Purdie and Anthony F. Lever and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gut.

In The Last Decade

A. Kraszewski

9 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Kraszewski United Kingdom	7	322	282	257	142	127	9	777
A. Clarke United Kingdom	7	456 1.4×	351 1.2×	260 1.0×	209 1.5×	212 1.7×	9	859
Tero Saukkonen Finland	21	90 0.3×	700 2.5×	436 1.7×	50 0.4×	248 2.0×	40	1.3k
P Fugère Canada	11	91 0.3×	109 0.4×	94 0.4×	49 0.3×	32 0.3×	21	391
A Fanconi Switzerland	16	15 0.0×	183 0.6×	70 0.3×	52 0.4×	261 2.1×	43	715
Kent V. Haderslev Denmark	11	118 0.4×	119 0.4×	45 0.2×	76 0.5×	73 0.6×	20	491
F. Glaser Germany	14	42 0.1×	25 0.1×	51 0.2×	287 2.0×	91 0.7×	39	643
O. Nájera Mexico	9	36 0.1×	158 0.6×	32 0.1×	94 0.7×	138 1.1×	10	797
Takanobu Anai Japan	11	67 0.2×	16 0.1×	18 0.1×	47 0.3×	40 0.3×	18	349
S D Hershey United States	7	55 0.2×	15 0.1×	26 0.1×	33 0.2×	51 0.4×	7	605
Mustafa Yaprak Türkiye	12	9 0.0×	87 0.3×	34 0.1×	67 0.5×	30 0.2×	53	415

Countries citing papers authored by A. Kraszewski

Since Specialization

Citations

This map shows the geographic impact of A. Kraszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Kraszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Kraszewski more than expected).

Fields of papers citing papers by A. Kraszewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Kraszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Kraszewski. The network helps show where A. Kraszewski may publish in the future.

Co-authorship network of co-authors of A. Kraszewski

This figure shows the co-authorship network connecting the top 25 collaborators of A. Kraszewski. A scholar is included among the top collaborators of A. Kraszewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Kraszewski. A. Kraszewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Bhutani, Manoop S., Jason Klapman, Richard Tuli, et al.. (2019). OncoPaC-1: An Open-label, Single-Arm Pilot Study of Phosphorus-32 Microparticles Brachytherapy in Combination with Gemcitabine +/- Nab-Paclitaxel in Unresectable Locally Advanced Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(1). E236–E237. 2 indexed citations

2.

Ross, Paul J., Daniel Croagh, Morteza Aghmesheh, et al.. (2019). PanCO: An open-label, single-arm pilot study of phosphorus-32 (P-32; Oncosil) microparticles in patients with unresectable locally advanced pancreatic adenocarcinoma (LAPC) in combination with FOLFIRINOX or gemcitabine + nab-paclitaxel (GNP) chemotherapies.. Journal of Clinical Oncology. 37(15_suppl). 4125–4125. 2 indexed citations

3.

Lindsay, Robert, D.M. Hart, & A. Kraszewski. (1980). Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.. BMJ. 280(6225). 1207–1209. 116 indexed citations

4.

Lindsay, R., D.M. Hart, Allan MacLean, et al.. (1979). Bone loss during oestriol therapy in postmenopausal women. Maturitas. 1(4). 279–285. 39 indexed citations

5.

Lindsay, Robert, D. M. Hart, D.W. Purdie, et al.. (1978). Comparative Effects of Oestrogen and a Progestogen on Bone Loss in Postmenopausal Women. Clinical Science. 54(2). 193–195. 139 indexed citations

6.

Lindsay, Robert, D. M. Hart, Allan MacLean, et al.. (1978). BONE RESPONSE TO TERMINATION OF OESTROGEN TREATMENT. Obstetrical & Gynecological Survey. 33(11). 741–743. 20 indexed citations

7.

Lindsay, Robert, Allan MacLean, A. Kraszewski, et al.. (1978). BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENT. The Lancet. 311(8078). 1325–1327. 235 indexed citations

8.

Weir, R. J., R. Fräser, Anthony F. Lever, et al.. (1973). PLASMA RENIN, RENIN SUBSTRATE, ANGIOTENSIN II, AND ALDOSTERONE IN HYPERTENSIVE DISEASE OF PREGNANCY. The Lancet. 301(7798). 291–294. 136 indexed citations

9.

Kraszewski, A., et al.. (1971). Intestinal spirochaetosis. Gut. 12(2). 126–133. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact